Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Hashimoto

Showing results (251-260 of 266) with videos related to

Pageof 27
Sort By:
Biomed Research International|October 28, 2021
Exploring Molecular Mechanisms Involved in the Development of the Depression-Like Phenotype in Interleukin-18-Deficient MiceKyosuke Yamanishi, Masahiro Miyauchi, Keiichiro Mukai, et al.
Angewandte Chemie (International Ed. in English)|January 31, 2017
Characterization of Giant Modular PKSs Provides Insight into Genetic Mechanism for Structural Diversification of Aminopolyol PolyketidesLihan Zhang, Takuya Hashimoto, Bin Qin, et al.
Japanese Journal of Clinical Oncology|April 12, 2022
Phase I/II study of streptozocin monotherapy in Japanese patients with unresectable or metastatic gastroenteropancreatic neuroendocrine tumorsIzumi Komoto, Norihiro Kokudo, Taku Aoki, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 29, 2017
CD44 Promotes Inflammation and Extracellular Matrix Production During Arteriovenous Fistula MaturationGo Kuwahara, Takuya Hashimoto, Masayuki Tsuneki, et al.
Neuroscience|April 15, 2019
Interleukin-18-deficient mice develop hippocampal abnormalities related to possible depressive-like behaviorsKyosuke Yamanishi, Nobutaka Doe, Keiichiro Mukai, et al.
JMA Journal|November 12, 2025
Sex Differences in Renal Outcomes and Metabolic Markers by Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists in Individuals with Type 2 Diabetes: A Post-Hoc Analysis of the RECAP StudyYoshimi Muta, Kazuo Kobayashi, Masao Toyoda, et al.
Nature|May 18, 2018
The onset of star formation 250 million years after the Big BangTakuya Hashimoto, Nicolas Laporte, Ken Mawatari, et al.
BJS Open|August 2, 2024
Japanese living donor liver transplantation criteria for hepatocellular carcinoma: nationwide cohort studyMasahiro Ohira, Gaku Aoki, Yasushi Orihashi, et al.
Diabetes & Vascular Disease Research|December 14, 2023
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medicationKazuo Kobayashi, Masao Toyoda, Atsuhito Tone, et al.
Diabetes, Obesity & Metabolism|May 20, 2024
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease, Shunichiro Tsukamoto, Kazuo Kobayashi, et al.
Pageof 27

Showing results (251-260 of 266) with videos related to

Sort By:
Pageof 27
Biomed Research International|October 28, 2021
Exploring Molecular Mechanisms Involved in the Development of the Depression-Like Phenotype in Interleukin-18-Deficient MiceKyosuke Yamanishi, Masahiro Miyauchi, Keiichiro Mukai, et al.
Angewandte Chemie (International Ed. in English)|January 31, 2017
Characterization of Giant Modular PKSs Provides Insight into Genetic Mechanism for Structural Diversification of Aminopolyol PolyketidesLihan Zhang, Takuya Hashimoto, Bin Qin, et al.
Japanese Journal of Clinical Oncology|April 12, 2022
Phase I/II study of streptozocin monotherapy in Japanese patients with unresectable or metastatic gastroenteropancreatic neuroendocrine tumorsIzumi Komoto, Norihiro Kokudo, Taku Aoki, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 29, 2017
CD44 Promotes Inflammation and Extracellular Matrix Production During Arteriovenous Fistula MaturationGo Kuwahara, Takuya Hashimoto, Masayuki Tsuneki, et al.
Neuroscience|April 15, 2019
Interleukin-18-deficient mice develop hippocampal abnormalities related to possible depressive-like behaviorsKyosuke Yamanishi, Nobutaka Doe, Keiichiro Mukai, et al.
JMA Journal|November 12, 2025
Sex Differences in Renal Outcomes and Metabolic Markers by Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists in Individuals with Type 2 Diabetes: A Post-Hoc Analysis of the RECAP StudyYoshimi Muta, Kazuo Kobayashi, Masao Toyoda, et al.
Nature|May 18, 2018
The onset of star formation 250 million years after the Big BangTakuya Hashimoto, Nicolas Laporte, Ken Mawatari, et al.
BJS Open|August 2, 2024
Japanese living donor liver transplantation criteria for hepatocellular carcinoma: nationwide cohort studyMasahiro Ohira, Gaku Aoki, Yasushi Orihashi, et al.
Diabetes & Vascular Disease Research|December 14, 2023
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medicationKazuo Kobayashi, Masao Toyoda, Atsuhito Tone, et al.
Diabetes, Obesity & Metabolism|May 20, 2024
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease, Shunichiro Tsukamoto, Kazuo Kobayashi, et al.
Pageof 27